← SynDRA
FOSFOMYCIN
SynDRA canonical compound SYN0020303 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Approval status | Approved · Rx/OTC |
|---|
| Mechanism of action | bacterial cell wall synthesis inhibitor |
|---|
| Indication | urinary tract infections |
|---|
| Disease area | infectious disease |
|---|
All known targets
- Bact murA
- murA
- murA1
- murA2
Mechanisms of action (all sources)
- bacterial cell wall synthesis inhibitor
- Inhibitor
- murA INHIBITOR
Drug classes
- Anti-Bacterial Agents
- Anti-Infective Agents
ATC classes
- S02A · ANTIINFECTIVES
- J01X · OTHER ANTIBACTERIALS
Cross-references
Synonyms
- fosfomycin trometamol
- fosfomycin tromethamine
- Fosfomycin calcium
- Fosfomycine
- Fosfomicina
- Fosfomycin calcium hydrate
- Fosfomycin sodium
- Calcium fosfomycin
- ZTI-01
- J01XX01
- NSC-758170
- Fosfocina
- FCM
- Phosphomycin
- Phosphonemycin
- Phosphonomycin
- Priomicina
- Veramina
- Disodium fosfomycin
- Disodium phosphonomycin
- Fosfocina disodium salt
- Fosfomycin disodium
- Fosfomycin disodium salt
- Fosfomycin sodium salt
- Fosmicin S
- Phosphomycin disodium salt
- Phosphonomycin disodium salt
- Phosphonomycin sodium
- Sodium fosfomycin
- MK 955
- FOM-Na
- Fosfomycin sodium (JP15)
- Fosmicin S (TN)
- Fosfomycin (USAN/INN)
- L-cis-1,2-epoxypropylphosphonic acid
- Disodium (1R,2S)-(1,2-epoxypropyl)phosphonate
- Disodium[(2r,3s)-3-methyloxiran-2-yl]phosphonate
- [(2R,3S)-3-methyloxiran-2-yl]phosphonic acid
Reported adverse events
- Asthenia
- Dizziness
- Dyspepsia
- Headache
- Nausea
Look up FOSFOMYCIN in the interactive SynDRA portal →